2
Feb 2026
Blood gene signals reveal Parkinson’s risk years before diagnosis
Blood-based DNA repair and stress-response signals reveal early molecular changes in Parkinson's disease, aiding in potential early diagnosis and intervention.
2
Feb 2026
Blood-based DNA repair and stress-response signals reveal early molecular changes in Parkinson's disease, aiding in potential early diagnosis and intervention.
2
Feb 2026
By analyzing tissue from patients with Parkinson's disease, and animal and cellular models of the disease, a research team from the Institut de Neurociències of the UAB has shown that the main immune cells of the brain become reactive and overexpress certain receptors that promote the elimination of dopaminergic neurons, even when these neurons are still functional.
2
Feb 2026
A national clinical trial led by the Alliance for Clinical Trials in Oncology has found that oxybutynin, a drug often used to treat overactive bladder symptoms, reduces hot flashes compared to the placebo in men receiving hormone therapy for prostate cancer.
2
Feb 2026
The study uncovers critical insights into sex-based heart disease risks, highlighting young adulthood as key for effective cardiovascular health interventions.
2
Feb 2026
Bone fractures usually heal efficiently, but in some patients this process fails, causing nonunion. A recent study identifies Apex1 as a redox-regulated driver of fracture repair.
2
Feb 2026
Two out of three adolescents with irritable bowel syndrome (IBS) start adulthood without the disease, according to a long-term study that followed more than 2,500 individuals.
2
Feb 2026
The study on Influenza D and Canine Coronavirus HuPn-2018 underscores urgent needs for targeted surveillance and diagnostics in infectious disease research.
2
Feb 2026
Daily physical activities play a far greater role in the well-being of patients with osteoarthritis than handgrip strength or isolated motor tasks, according to new research from the University of Sharjah.
2
Feb 2026
People born more recently are being diagnosed with psychotic disorders (e.g., schizophrenia) more often and at younger ages than people born earlier, suggests a large study of more than 12 million people in Ontario, published in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.250926.
2
Feb 2026
A key focus of the segment is Sino Biological’s ProPure™ line of ultra-pure, endotoxin-free recombinant proteins, produced at its state-of-the-art Houston Center for Bioprocessing.
Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more
Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more
Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more